Skip to search formSkip to main contentSkip to account menu

Factor Xa Inhibitor [EPC]

Known as: Factor 10a Inhibitor, Activated Factor X Inhibitor, Activated Factor 10 Inhibitor 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Antithrombin III
Factor Xa inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Evaluation of Factor Xa-Specific Chromogenic Substrate Assays and the Determination of Pharmacokinetics of Fondaparinux
Fondaparinux (FPX), a synthesized factor Xa inhibitor, is one of the most popular anticoagulants for the prevention of… 
2015
2015
Dual antiplatelet agents and Rivaroxaban for massive intracoronary thrombus in STEMI
Management of intracoronary thrombus in patients presenting more than 12 hours after the onset of ST elevation myocardial… 
Review
2013
Review
2013
The Cost‐Effectiveness of Oral Direct Factor Xa Inhibitors Compared with Low‐Molecular‐Weight Heparin for the Prevention of Venous Thromboembolism Prophylaxis in Total Hip or Knee Replacement Surgery
Major orthopedic surgery is associated with a high risk of venous thromboembolism (VTE). Anticoagulants are recommended to… 
2013
2013
Clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban, an oral direct factor Xa inhibitor, in healthy Caucasian and Japanese subjects
Background. Darexaban (YM150) is a potent direct factor Xa (FXa) inhibitor developed for the prophylaxis of venous and arterial… 
2013
2013
Efficacy and Safety of Apixaban in Patients Following Cardioversion for Atrial Fibrillation: Insights from the ARISTOTLE trial
Objectives: To determine the risk of major clinical and thromboembolic events after cardioversion for atrial fibrillation in… 
2013
2013
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Darexaban, an Oral Direct Factor Xa Inhibitor, in Healthy Elderly Japanese Subjects
The clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban after single and multiple once‐daily doses… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)